“Is there any discussion about DG Sante’s continued future? The answer is simply no,” says EU Commission’s Director General for Health and Food Safety Xavier Prats Monné
The founders of the Diabeter clinics ditched secure jobs to embrace a new model of specialist care. Ten years on, they have the best paediatric glucose control outcomes and lower costs than most other providers
For patients who undergo complex abdominal operations in the US, poor transitions from the hospital to home contribute to hospital readmission rates ranging from 13 to 30 percent
Efforts to reduce hospital readmissions are working, but they are not always saving money, according to a new study by healthcare provider Cedars-Sinai, which systematically evaluated the effectiveness and financial benefit of quality improvement programmes at medical centres in the US and elsewhere.
The US health plan Harvard Pilgrim Health Care has signed two outcomes-based contracts with AstraZeneca for its acute coronary disease drug Brilinta and Bydureon, a treatment for Type II diabetes, in which the cost of the drugs will be linked to their effectiveness in actual patients.
New analysis finds the extremely competitive research programme is rejecting more and more great proposals. The success rate is down from 18.5% in FP7 to a lowly 11.6% now
Romanian government drops foreign evaluators from its national funding schemes and cuts science funding as the EU gears up for the next research framework programme
The Hungarian government and New York governor Andrew Cuomo to start talks that may end threat that a new higher education law would force CEU to close its Budapest campus
Small and growing companies will enjoy better access to finance on the back of new EU rules agreed as part of the Commission's drive to stimulate venture capital investment
A ranking of the world’s clusters on the basis of patent filings puts Tokyo-Yokohama in Japan first by a large margin. The top-ranked in Europe is Paris in 10th place
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.